Results 161 to 170 of about 1,034,952 (285)

Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis- causes and implication on outcomes in a population-based study. [PDF]

World J Surg Oncol
Lepsenyi M, Valdimarsson V, Algethami N, Thorlacius H, Ghanipour L, Cashin P, Asplund D, Lindskog EB, Palmer GJ, Nilsson PJ, Syk I.   +10 more
europepmc   +1 more source

Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies

Chemistry – A European Journal, EarlyView.
The synthesis of multicomponent cancer vaccines on AuNP carriers could be rationalized by the simultaneous functionalization of the antigen and immunomodulator components on the same particles. Immunization with a “diluted” amount of MUC1‐functionalized AuNPs is still capable of eliciting a strong immune response.
Mattia Ghirardello, Ana Guerreiro, Carmen Bretón, Ismael Compañón, Julio Zabalza, Vincenzo Mangini, Jesús M. Peregrina, Gonçalo J. L. Bernardes, Francisco Corzana   +8 more
wiley   +1 more source

An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. [PDF]

Ann Surg Oncol
Liu D, Chen Z, Deng W, Lan J, Zhu Y, Wang H, Xu X, Zhang Y, Wu X, Yang K, Cai J.   +10 more
europepmc   +1 more source

Worldwide barriers of optimal surgical care provision in advanced ovarian cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Ovarian cancer (OC) remains one of the most challenging gynecological malignancies to cure, despite recent advances in treatment. Disparities in the diagnosis, management, and survival of OC exist worldwide and addressing them remains an ongoing challenge.
Shriya Varghese, Myong Cheol Lim, Robert Armbrust, Rene Pareja, Christina Fotopoulou   +4 more
wiley   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience. [PDF]

BMC Cancer
Dinçer B, Gök AFK, İlhan M, Ercan LD, Kulle CB, Ercan CC, Berker N, Ertekin C.   +7 more
europepmc   +1 more source

Targeting the ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti‐VEGF resistance in endometrial cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate the role of ST3 beta‐galactoside alpha‐2,3‐sialyltransferase 1 (ST3Gal1) in endometrial cancer (EC) progression and its potential as a therapeutic target to enhance the efficacy of antiangiogenic treatment. Methods ST3Gal1 expression and its clinical relevance were analyzed in EC tissues.
Chia‐Hao Liu, Szu‐Ting Yang, Wei‐Ting Chao, Chen‐Hao Lin, Yu‐Chieh Lee, Chiung‐Ru Lai, Shie‐Liang Hsieh, Liang‐Wei Wang, Peng‐Hui Wang   +8 more
wiley   +1 more source

Novel inflammatory-nutritional prognostic index for advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy. [PDF]

World J Gastrointest Surg
Wang L, Chen MZ, Liu L, Jiang ZN, Zhang SM, Zhang MS, Zhang XX, Liu RQ, Wang DS.   +8 more
europepmc   +1 more source

A Hiplot‐based web service for cold atmospheric plasma high‐throughput data integration and analysis on breast cancer

iMeta, EarlyView.
Cold atmospheric plasma (CAP) represents an emerging onco‐therapeutics that can specifically ablate cancer cells without harming their healthy peers via redox perturbation. CAP medicine in breast cancer (CAPmed‐BC) is the first reservoir of multi‐level omics data including whole transcriptome, acetylome, lactylome, proteome, phosphorylome that records ...
Xiaofeng Dai, Mingjie Wang, Yang Liu
wiley   +1 more source

Perfusion Instability During Hyperthermic Intraperitoneal Chemotherapy: The Utility of a Problem-solving Flowchart. [PDF]

In Vivo
Soligo C, Cenzi C, Foscaro F, Bordignon B, Savi S, Perdonò P, Munaretto G, Visentin F, Tarantino T, Cerato A, Pilati P, Cabianca R, Sommariva A.   +12 more
europepmc   +1 more source

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models

Cancer Communications, EarlyView.
Monika Raab, Balázs Győrffy, Samuel Peña‐Llopis, Daniela Fietz, Monika Kressin, Margareta Kolaric, Matthias Ebert, Khayal Gasimli, Sven Becker, Mourad Sanhaji, Klaus Strebhardt   +10 more
wiley   +1 more source